Frequency of Diabetes Mellitus in Females with Breast Cancer

Authors

  • Ragda Imran Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
  • Haider Ali Department of Orthopedics, Allied Hospital, Faisalabad, Pakistan.
  • Muhammad Arslan Department of Infectious Diseases and Internal Medicine, Mujahid Hospital, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i5.1464

Keywords:

Breast Cancer, Diabetes Mellitus, HbA1c

Abstract

Objective: “To determine the frequency of diabetes in patients with breast cancer. Study Design: Cross sectional study. Place of study and duration: Department of Medicine, Shaukat Khanum Memorial Cancer Hospital & Research Center Lahore for 6 months from 1st July 2024 to 31st December 2024. Patients & Methodology: One hundred and forty patients with breast cancer were enrolled through non-probability consecutive sampling technique. About 3ml blood sample was taken for assessment of HbA1c. Reports were assessed and if HBA1c>6.5%, then diabetes was labeled. Results: In this study the mean age of the participants was 50.84 ± 8.61 years, with a mean BMI of 24.48 ± 3.94 kg/m² and 42 (30%) had hypertension. A family history of breast cancer was reported in 25 (17.9%) participants. among 140 breasts cancer females 27 (19.29%) were diabetics. Diabetes was present in 4 (5.9%) patients aged ≤50 years, while in 23 (31.9%) older than 50 years (p-value <0.001). Diabetes was more common among overweight and obese patients 17 (26.6%) as compared to patients with normal BMI [10 (13.2%)] (p-value = 0.045). Diabetes was more common in patients with advanced stage cancer [11 (25.0%) in Stage II and 15 (26.8%) in stage III] than stage I [1 (2.5%), p-value = 0.006). Diabetes was significantly more prevalent in hypertensive patients [24 (57.1%)] than non-hypertensive [3 (3.1%), p-value <0.001). Patients receiving chemo- as well as radiotherapy are at more risk of diabetes (100%) as compared to patients receiving only chemotherapy (6%) or radiotherapy (18.5%). Conclusion: On the findings of this study, we may conclude that frequency of diabetes mellitus is 19.29% in females presenting with breast cancer.

Downloads

Download data is not yet available.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394-424.

https://doi.org/10.3322/caac.21492

Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173(2):291-304. e6.

Abudawood M. Diabetes and cancer: a comprehensive review. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2019;24.

https://doi.org/10.4103/jrms.jrms_242_19

Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, et al. Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiology, Biomarkers & Prevention. 2018;27(1):50-7.

https://doi.org/10.1158/1055-9965.epi-17-0439

Storey S, Cohee A, Gathirua-Mwangi WG, Vachon E, Monahan P, Otte J, et al., editors. The impact of diabetes on the symptoms of breast cancer survivors. Oncology nursing forum; 2019: NIH Public Access.

https://doi.org/10.1188/19.onf.473-484

Vrinzen CE, Delfgou L, Stadhouders N, Hermens RP, Merkx MA, Bloemendal HJ, et al. A systematic review and multilevel regression analysis reveals the comorbidity prevalence in cancer. Cancer Research. 2023;83(7):1147-57.

https://doi.org/10.1158/0008-5472.can-22-1336

Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK, Amir E, et al. The impact of diabetes on breast cancer treatments and outcomes: a population-based study. Diabetes care. 2018;41(4):755-61.

https://doi.org/10.2337/dc17-2012

Durrani IA, Bhatti A, John P. The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis. Cancer Cell International. 2021;21(1):351.

https://doi.org/10.1186/s12935-021-02040-5

Tabassum I, Mahmood H, Faheem M. Type 2 Diabetes Mellitus as a Risk Factor for Female Breast Cancer in the Population of Northern Pakistan. Asian Pacific journal of cancer prevention : APJCP. 2016;17(7):3255-8.

Cuadros DF, Li J, Musuka G, Awad SF. Spatial epidemiology of diabetes: methods and insights. World journal of diabetes. 2021;12(7):1042.

https://doi.org/10.4239/wjd.v12.i7.1042

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA: a cancer journal for clinicians. 2010;60(4):207-21.

https://doi.org/10.3322/caac.20078

Eketunde AO. Diabetes as a Risk Factor for Breast Cancer. Cureus. 2020;12(5):e8010.

https://doi.org/10.7759/cureus.8010

Women’s College Hospital. Women with diabetes more likely to be diagnosed with advanced stage breast cancer: Women’s College Hospital; 2015 [cited 203].

https://www.eurekalert.org/pub_releases/2015-03/wch-wwd032415.php.

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. Diabetes care. 2010;33(7):1674-85.

https://doi.org/10.2337/dc10-0666

Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. Diabetes and breast cancer risk: a meta-analysis. British journal of cancer. 2012;107(9):1608-17.

https://doi.org/10.1038/bjc.2012.414

Sharifi Nasab M, Yazdimoghaddam H, Mohaddes ST, Rakhshani MH, Abbaszadeh Goudarzi K. The Association Between Diabetes Mellitus With a Five-year Survival Rate of Breast Cancer Patients. Journal of Research and Health. 2022;12(1):33-40.

https://doi.org/10.32598/jrh.12.1.1937.1

Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, et al. Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. British Journal of Cancer. 2023;129(4):648-55.

https://doi.org/10.1038/s41416-023-02345-4

Zhao XB, Ren GS. Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016;95(49):e5602.

https://doi.org/10.1097/md.0000000000005602

Ferroni P, Riondino S, Laudisi A, Portarena I, Formica V, Alessandroni J, et al. Pretreatment insulin levels as a prognostic factor for breast cancer progression. The oncologist. 2016;21(9):1041-9.

https://doi.org/10.1634/theoncologist.2015-0462

Bronsveld HK, Peeters PJ, De Groot MC, de Boer A, Schmidt MK, De Bruin ML. Trends in breast cancer incidence among women with type-2 diabetes in British general practice. Primary care diabetes. 2017;11(4):373-82.

https://doi.org/10.1016/j.pcd.2017.02.001

Downloads

Published

2025-05-28

How to Cite

Imran, R., Ali, H., & Arslan , M. (2025). Frequency of Diabetes Mellitus in Females with Breast Cancer. Indus Journal of Bioscience Research, 3(5), 703–706. https://doi.org/10.70749/ijbr.v3i5.1464

Most read articles by the same author(s)